1. EXTH-44. PERSONALIZED IMMUNOTHERAPY VACCINES FOR GLIOBLASTOMA AND THEIR TREATMENT EFFICACY. (14th November 2022) Authors: Trivedi, Vrunda; Yang, Changlin; Fenton, Graeme; Yegorov, Oleg; Von Roemeling, Christina; Klippel, Kelena; Ogando-Rivas, Elizabeth; Castillo, Paul; Hoang-Minh, Lan; Dyson, Kyle; Moore, Ginger; Mitchell, Duane Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EXTH-92. TARGETING PRIMARY CENTRAL NERVOUS SYSTEM B CELL LYMPHOMA IGH CLONOTYPES USING NOVEL RNA-NPS. (14th November 2022) Authors: Ogando-Rivas, Elizabeth; Von Roemeling, Christina; Castillo, Paul; Liu, Ruixuan; Mendez-Gomez, Hector; Thomas, Nagheme; Weidert, Frances; Chardon-Robles, Jonathan; Qdaisat, Sadeem; Cascio, Matthew; Ligon, John; Huang, Jianping; Mitchell, Duane; Sayour, Elias Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EXTH-93. THE IRAK-4 INHIBITOR EMAVUSERTIB (CA-4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA. (14th November 2022) Authors: von Roemeling, Christina; Doonan, Bently; Klippel, Kelena; Hoang-Minh, Lan; Ogando-Rivas, Elizabeth; Martinez, Elizabeth; Castillo, Paul; Iqbal, Madiha; Tun, Han; von Roemeling, Reinhard; Mitchell, Duane Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. IMMU-27. IMMUNE CHECKPOINT BLOCKADE OF EX VIVO EXPANDED T CELLS FOR USE IN ADOPTIVE CELLULAR THERAPY (ACT) FOR GLIOBLASTOMA. (11th November 2019) Authors: Ogando-Rivas, Elizabeth; Yang, Changlin; Castillo, Paul; Dechkovskaia, Anjelika; Mitchell, Duane Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. IMMU-29. LAG-3 COMPENSATES TIM-3 DOWN-REGULATION IN A HUMAN GLIOBLASTOMA MODEL. (9th November 2020) Authors: Ogando-Rivas, Elizabeth; Castillo-Caro, Paul; Jones, Noah; Dechkovskaia, Anjelika; Yang, Changlin; Mitchell, Duane Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. IMMU-52. EFFECTS OF IMMUNE CHECKPOINT BLOCKADE ON ANTIGEN-SPECIFIC CD8+ T CELLS FOR USE IN ADOPTIVE CELLULAR THERAPY. (12th November 2021) Authors: Ogando-Rivas, Elizabeth; Castillo, Paul; Jones, Noah; Trivedi, Vrunda; Drake, Jeffrey; Dechkovskaia, Anjelika; Candelario, Kate; Yang, Changlin; Mitchell, Duane Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Letter: Lower Risk of Intracranial Arteriovenous Malformation Hemorrhage in Patients With Hereditary Hemorrhagic Telangiectasia. Issue 2 (1st February 2017) Authors: Ogando-Rivas, Elizabeth; Mendoza, Jesús Quetzalcóatl Beltrán Journal: Neurosurgery Issue: Volume 80:Issue 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Letter: Lower Risk of Intracranial Arteriovenous Malformation Hemorrhage in Patients With Hereditary Hemorrhagic Telangiectasia. Issue 2 (30th January 2017) Authors: Ogando-Rivas, Elizabeth; Mendoza, Jesús Quetzalcóatl Beltrán Journal: Neurosurgery Issue: Volume 80:Issue 2(2017) Page Start: E191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗